The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Gemma left some of her 2.2 million social media followers in awe when she mentioned she had partnered with Yazen, a company ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Gemma Collins has shown off a huge body transformation in the new year, revealing she's already two dress sizes smaller this ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Gemma Collins has revealed that she's using weight loss jabs to help her slim down, but the former TOWIE star is no stranger ...

EXCLUSIVE: Gemma Collins shocked fans by revealing she's taking weight loss injections and has already shrunk by two dress ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

The evolution of AI, more limited-time product offerings and GLP-1 use for weight loss are among the issues expected to play ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...

The cost to taxpayers could be enormous.Sales growth of Zepbound in the U.S. has been constrained by rules that bar Medicare, ...